Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Literature
1.
Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron. 1997;77:176–85.CrossRef
2.
Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071–84.CrossRef
3.
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–98.CrossRef
4.
Tsubakihara Y, Gejyo F, Nishi S, Iino Y, Watanabe Y, Suzuki M, Saito A, Akiba T, Hirakata H, Akizawa T. High target hemoglobin with erythropoiesis-stimulating agents has advantages in the renal function of non-dialysis chronic kidney disease patients. Ther Apher Dial. 2012;16:529–40.CrossRef
5.
Covic A, Nistor I, Douciu MD, Dumea R, Bolignanob D, Goldsmith D. Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic disease: a meta-analysis of 19 studies. Am J Nephrol. 2014;40:263–79.CrossRef
Metadata
Title
Early renoprotection by anemia correction
Author
Satoru Kuriyama
Publication date
01-10-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 5/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1554-6

Other articles of this Issue 5/2018

Clinical and Experimental Nephrology 5/2018 Go to the issue

Original article

The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study

Original article

Low serum phosphate is associated with ischemic stroke in hemodialysis patients

Original Article

Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome

Original article

Visit-to-visit blood pressure variability in children and adolescents with renal disease

Original article

Defective renal autoregulation in the chronic bile duct ligation model of liver failure

Images in Nephrology

Renal hemosiderosis with uncontrolled hypertension

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits